-
FDA Approval of Emrosi for Rosacea Treatment
FDA
FDA approves Journey Medical's Emrosi?, a 40 mg extended-release minocycline capsule, for treating adult rosacea. Supported by successful Phase III trials, Emrosi is set to launch in the U.S. by mid-2025 as a new oral standard for rosacea treatment.
元氏县|
仁寿县|
汤原县|
永济市|
札达县|
寻乌县|
乌鲁木齐县|
铜鼓县|
延庆县|
昭平县|
迁安市|
西平县|
都安|
新乡市|
乌鲁木齐县|
华容县|
石嘴山市|
长乐市|
奉节县|
秦安县|
石楼县|
仙游县|
资源县|
剑川县|
江城|
凤城市|
临沭县|
天峨县|
赫章县|
喀什市|
清原|
广灵县|
阿城市|
江山市|
三明市|
信丰县|
铜鼓县|
宜丰县|
武平县|
庆安县|
九台市|